Skip to content

New hepatitis C protease inhibitors achieve 80% ‘cure’ rate in patients with genotype 1 infection

Punching fog – how people with HIV are tackling stigma worldwide

How does HIV make us sick?

Lost to care: the mystery of the disappearing patients

Are we thinking clearly about brain impairment?

President Obama announces US HIV travel ban will end in January 2010

Darunavir/ritonavir, etravirine and raltegravir combination has 'remarkable' success in children with resistant virus

Retention in opioid replacement programmes improves chances of HIV treatment working for drug users

High prevalence of anal chlamydia in Swiss HIV-positive gay men